Volume 1, Number 2Review ArticlesTelemedicine and Surgical Robotics: Urologic ApplicationsTechniques & TechnologyLouis KavoussiJeffrey A CadedduBenjamin R LeeDan StoianoviciRoboticsTelemedicinePercutaneous access
Volume 12, Number 3Meeting ReviewsUro-Oncological Controversies in Euro-OncologyMeeting ReviewMike HarikMarkus MargreiterHelen SadriElisabeth EckersbergerAlexander FarrBob DjavanHerbert LeporHighlights From the European Association of Urology Section of Oncological Urology, January 15-17, 2010, Vienna, Austria [Rev Urol. 2010;12(2/3):e125-e128 doi: 10.3909/riu0491]Prostate cancer screeningBladder cancerRenal cancerRoboticsCancer mortality rates
Volume 12, Number 1Review ArticlesOpen Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US ExperienceTreatment UpdateJulia FinkelsteinHelen SadriHerbert LeporElisabeth EckersbergerBob DjavanSamir S TanejaOpen radical prostatectomy (ORP) is the reference standard for the surgical management of localized prostate cancer. With wider availability of minimally invasive radical prostatectomy techniques, there is a debate regarding the standard treatment of the management of localized prostate cancer. Therefore, we reviewed the current status of laparoscopic radical prostatectomy (LRP) and robotic-assisted laparoscopic radical prostatectomy (RALRP) as compared with ORP. Because no prospective, randomized trials comparing the different techniques have been performed, outcomes must be assessed from published series by centers that focus on ORP, LRP, and RALRP. Aside from reducing the amount of blood loss, current data suggest that the most significant outcomes (cure, continence, and potency) are no better with LRP or RALRP than with conventional ORP. Therefore, in experienced hands, ORP remains the gold standard procedure. However, there is a trend toward consistently better outcomes following RALRP in comparison with LRP. In the end, individual patient outcomes can be maximized by choosing the best modality based on the patient’s comorbid medical conditions, cancer characteristics, and surgeon experience. Future studies are needed to further investigate long-term cancer control as well as functional outcomes for RALRP series.[Rev Urol. 2010;12(1):35-43 doi: 10.3909/riu0470]Prostatic neoplasmsLaparoscopyProstatectomyRobotics